Phase 1, multiple, ascending-dose study of BIIB033 in patients with relapsing-remitting multiple sclerosis (RRMS) or secondary-progressive multiple sclerosis (SPMS)

Trial Profile

Phase 1, multiple, ascending-dose study of BIIB033 in patients with relapsing-remitting multiple sclerosis (RRMS) or secondary-progressive multiple sclerosis (SPMS)

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Apr 2014

At a glance

  • Drugs Opicinumab (Primary)
  • Indications Multiple sclerosis
  • Focus Pharmacodynamics
  • Sponsors Biogen Idec
  • Most Recent Events

    • 28 Apr 2014 Results presented at the 66th Annual Meeting of the American Academy of Neurology.
    • 23 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top